| Business Summary | | Careside,
Inc.
has
developed
and
sells
a
proprietary
blood
testing
system,
designed
to
decentralize
laboratory
operations.
The
system
provides
cost-effective,
accurate
test
results
within
10
to
15
minutes
at
the
point
of
care
for
a
comprehensive
menu
of
routine
blood
tests.
Because
it
provides
rapid
test
results,
the
Company's
system
can
also
perform
blood
tests
required
for
critical
care
testing.
As
of
year-end
2000,
the
Careside
system
performed
chemistry,
electrochemistry,
coagulation
and
hematology
tests.
The
Company
plans
to
offer
immunochemistry
tests
for
the
Careside
system
later
in
2001. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Careside,
Inc.,
is
engaged
in
designing
products
intended
to
perform
routine
diagnostic
blood
tests
in
doctors'
offices,
hospital
rooms,
patient
homes
or
anywhere
a
patient
is
receiving
medical
attention.
For
the
three
months
ended
3/31/01,
revenues
fell
35%
to
$184
thousand.
Net
loss
applicable
to
Common
fell
20%
to
$3.4
million.
Revenues
reflect
the
shift
in
effort
by
the
Company
to
sell
its
Careside
Analyzers.
Lower
loss
reflects
the
completion
of
a
third
party
contract. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| W. Vickery Stoughton, 54 Chairman
and CEO | $270K | James Koch, 46 CFO,
Exec. VP, Treasurer | 196K | Dennis Reiger, 55 Sr.
VP, Information Technology and CIO | 184K | Sandra Twyon, 62 VP-Operations | 166K | Thomas Grove, Ph.D., 51 CTO,
Exec. VP, Sec. | 202K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|